Evidence map›Paper›PMID 24323710›Full record

ReviewTranslational stroke research2014

Tumor necrosis factor-α modulates cerebral aneurysm formation and rupture.

Robert M Starke, Daniel M S Raper, Dale Ding, Nohra Chalouhi, Gary K Owens, David M Hasan, Ricky Medel, Aaron S Dumont

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Translational stroke research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02638701 (Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms), which is not on this map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02638701 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

TypeinterventionalSponsorUniversity of California, San FranciscoRan2024 to 2028Enrolled8ConditionsAneurysm, Stroke, Vasculitis, Tumor Necrosis Factor-alphaArmsInfliximab
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Molecular Targets for Intracranial Aneurysm Treatment.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Novel insight into ferroptosis-related genes, molecular subtypes, and immune characteristics in intracranial aneurysms.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  9. Article
  10. Article
  11. Understanding the genetics of intracranial aneurysms: A primer.Clinical neurology and neurosurgery · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Robert M StarkeDepartment of Neurological Surgery, University of Virginia, Charlottesville, VA, USA.
Daniel M S Raper
Dale Ding
Nohra Chalouhi
Gary K Owens
David M Hasan
Ricky Medel
Aaron S Dumont
Neurological Surgery · USUniversity of Virginia · USThomas Jefferson University · USTulane University · USUniversity of Iowa · US

Funding

TNF-a and vascular smooth muscle cell phenotypic modulation in cerebral aneurysmsK08NS067072 · NINDS · UNIVERSITY OF VIRGINIA · PI DUMONT, AARON S · 2009 to 2013
$886k
NINDS NIH HHS 1K08NS067072NINDS NIH HHS K08 NS067072
6 · The paper itself

Abstract

Inflammation is a critical process behind cerebral aneurysm formation and rupture. Tumor necrosis factor alpha (TNF-α) is a key immune modulator that has been implicated in cerebral aneurysm pathophysiology. This may occur through TNF-α-mediated endothelial injury, smooth muscle cell phenotypic modulation, recruitment of macrophages, activation of chemotactic cytokines, upregulation of matrix remodeling genes, production of free radicals leading to oxidative stress, and ultimately cellular apoptosis. Recent studies have indicated that TNF-α may be a potential target for the development of novel medical therapies, but additional experimental data is needed to clarify the intricacies of TNF-α activation and its critical downstream targets in cerebral aneurysms. This review provides an update on the mechanisms underlying TNF-α-induced molecular modulation in cerebral aneurysms.

Indexed as

Aneurysm, RupturedAnimalsDisease Models, AnimalHumansInflammationIntracranial AneurysmOxidative StressTumor Necrosis Factor-alphaTumor Necrosis Factor-alpha

Identifiers

PMID24323710
OpenAlexW2092365611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.